Liege, June 25-27 2014 - 8th ICHBB

Condividi su
Data dell'evento: dal 25/06/2014 al 27/06/2014
liege

8th International Conference on Hormones Brain and Behavior (ICHBB)
Official retirement of Jacques BALTHAZART, University of Liege
Liege, June 25-27, 2014

The 8th ICHBB was a great success with a rich scientific program and a number of speakers of high value. The conference was opened by a lecture from Peg McCarthy and continued with 6 symposia dedicated to:
- sexual differentiation
- sexual and social motivations
- aromatase and estrogen action
- neuroprotection and endocrine disruption
- seasonality and plasticity
- brain plasticity.
Giancarlo Panzica, NICO, gave a lecture on "Sexually dimorphic effects of endocrine disruptors on brain and behavior".
Additonal plenary lectures were from Barney Schlinger and Greg Ball.
The conference was organized to honour the official retirement of Jacques Balthazart. Therefore all the speakers contributed with their personal knowledge about Jacques, his personality, his role in behavioral research, his teaching and mentoring activity.
Program

Agenda

16 febbraio 2019

Torino - 10th International Meeting STEROIDS and NERVOUS SYSTEM

Since 2001, this meeting represented an important event for basic and clinical researchers working on this emerging scientific topic. We will address state-of-the-art approaches in the field of steroids and nervous system, including behavior, epigenetics, genomic and non-genomic actions, the vitamin D, neurodegenerative and psychiatric disorders, and the interference among endocrine disruptors and steroid signaling.

Ricerca

Identificato un nuovo bersaglio per contrastare la SMA

L’inibizione della proteina JNK rallenta la progressione della malattia che colpisce i motoneuroni ed è la prima causa genetica di morte nell’infanzia. Lo dimostra uno studio pubblicato su Frontiers in Molecular Neuroscience dal nostro gruppo di ricerca guidato da Alessandro Vercelli, in collaborazione con l’Istituto Mario Negri di Milano. Chiarire i meccanismi molecolari alla base della SMA può aprire la strada allo sviluppo di nuove terapie.

24 ottobre 2018